Englander Institute for Precision Medicine

Where are we going with gene screening for male infertility?

TitleWhere are we going with gene screening for male infertility?
Publication TypeJournal Article
Year of Publication2019
AuthorsThirumavalavan N, J Gabrielsen S, Lamb DJ
JournalFertil Steril
Volume111
Issue5
Pagination842-850
Date Published2019 May
ISSN1556-5653
KeywordsChromosome Deletion, Chromosomes, Human, Y, Genetic Testing, Humans, Infertility, Male, Karyotyping, Male, Protein Array Analysis, Sex Chromosome Aberrations, Sex Chromosome Disorders of Sex Development
Abstract

Male infertility is a heterogenous disease process requiring the proper functioning and interaction of thousands of genes. Given the number of genes involved, it is thought that genetic causes contribute to most cases of infertility. Identifying these causes, however, is challenging. Infertility is associated with negative health outcomes, such as cancer, highlighting the need to further understand the genetic underpinnings of this condition. This paper describes the genetic and genomic tests currently available to identify the etiology of male infertility and then will discuss emerging technologies that may facilitate diagnosis and treatment of in the future.

DOI10.1016/j.fertnstert.2019.03.036
Alternate JournalFertil Steril
PubMed ID31029238
Grant ListR01 DK078121 / DK / NIDDK NIH HHS / United States

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021